BacoCure Israeli Company
BacoCure is developing a novel bacterial product for local therapy (intravesicular) of patients with non-muscle invasive bladder cancer. BacoCure's lead product is a novel mutated and inactivated uropathogenic bacteria that has demonstrated impressive anti-tumor effects via a novel and differentiated mechanism of action with a better safety profile compared to Bacillus Calmette-Guerin. The product is at an advanced preclinical development stage.
Health Tech & Life Sciences
Biotechnology
Health Care
Life Science
Pharmaceutical
Alternatives
No alternatives listed yet.
Suggest an Alternative
Parent Companies/Investors
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/bacocure
[2]
crunchbase.com
- https://www.crunchbase.com/organization/bacocure
External links are provided for reference and verification purposes.